Flavia Laffleur

Dr. Flavia Laffleur


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FLFlavia Laffleur
Flavia Laffleur
BBBettina Bauer
Bettina Bauer

1 November 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FLFlavia Laffleur
Flavia Laffleur
VKValérie Keckeis
Valérie Keckeis

3 April 2022 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Open access
EAEva Sanchez Armengol
Eva Sanchez Armengol
AUAlexander Unterweger
Alexander Unterweger
FLFlavia Laffleur
Flavia Laffleur
Target-site drug delivery systems are gaining interest in the pharmaceutical field due to their great advantages, such as higher drug dosing capacity and better bioavailability. However, some existing problems need to be overcome. As an example, interaction between blood proteins and drug delivery systems. A potent candidate to approach the mentioned problem is based on polyethylene glycol (PEG) surface modifications. This polymer acts as a protector towards the external possible interactions with other compounds, making targeted delivery possible. Diseases such as cancer, diabetes, haemophilia and pain treatment can benefit from these new systems. This review aims to give an overview of drug delivery systems based on PEGylation as surface modification as pharmaceutical approach. Moreover, a deeper insight of the properties of PEG and its advantages is given, as well as brief overview of present therapies based on this technology.

1 November 2021 in Microbiological Research
Verified
Journal Article
Open access
EAEva Sanchez Armengol
Eva Sanchez Armengol
MHMelisa Harmanci
Melisa Harmanci
FLFlavia Laffleur
Flavia Laffleur
Fungal and microbial infections are increasingly common diseases affecting not only humans, but also animals. Despite the fact that there are wide ranges of antifungal drugs that can be used as therapy against different types of mycosis, the large-scale needed for new antifungal and antimicrobial agents is undeniable. The reasons for a great demand for new agents are low effectiveness due to the development of resistance, host toxicity and various side effects of currently used therapeutics. In order to develop novel drugs against fungal infections, scientists need to search for new molecules that show antimicrobial activity. However, there are various methods to determine antifungal and antimicrobial activity such as diffusion methods, bioautography methods, dilution methods and other frequently used methods. This review aims to explain the methodologies mentioned, to highlight the functioning, usage, advantages and disadvantages and to compare the techniques using different sources of the last years. Additionally, some of the currently investigated natural compounds such as essential oils, which show promising results in the medication of fungal diseases, are mentioned.

1 September 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
FLFlavia Laffleur
Flavia Laffleur
MMMartina Michalek
Martina Michalek

1 August 2014 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
FLFlavia Laffleur
Flavia Laffleur
JRJulia Röggla
Julia Röggla
MIMuneeb Ahmad Idrees
Muneeb Ahmad Idrees
JGJulia Griessinger
Julia Griessinger